The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future.
Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.
Details of payments and benefits in kind made by pharmaceutical companies to UK health professionals and organisations can be found on Disclosure UK.
In a recent report, Disclosure UK was named as the most accessible of European platforms for finding this information.
About Disclosure UK
Disclosure UK is a searchable database, published on the ABPI's website, detailing 'transfers of value' – payments and benefits in kind made to UK HCPs and HCOs by pharmaceutical companies.
The database, launched in June 2016, is updated annually with the previous year's disclosures and contains details of certain payments and other benefits in kind made to HCPs unless there is a legal reason why a particular HCP cannot be individually named.
The annual publication of this data on Disclosure UK is a requirement of the ABPI's Code of Practice for the Pharmaceutical Industry. It is part of a Europe-wide transparency initiative spanning 33 countries, which are all making these payments and benefits in kind public every year.